Literature DB >> 7454176

Metronidazole in breast milk.

S H Erickson, G L Oppenheim, G H Smith.   

Abstract

Breast milk concentrations of metronidazole were assayed in 3 women who had been treated with a single 2.0-g dose for trichomoniasis. Highest concentrations of the drug were found 2 and 4 hours after administration, and they declined over the next 12 to 24 hours. It appears that if breast-feeding is withheld for 12 to 24 hours after the dose, infants will be exposed to a greatly reduced amount of metronidazole. As the use of metronidazole in nursing mothers is currently not recommended, this may be the regimen of choice for the treatment of trichomoniasis in lactating women.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7454176

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  19 in total

Review 1.  Antibiotics and breast-feeding: a critical review of the literature.

Authors:  Allison M Chung; Michael D Reed; Jeffrey L Blumer
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Hyperpolarizing Concentrated Metronidazole 15 NO2 Group over Six Chemical Bonds with More than 15 % Polarization and a 20 Minute Lifetime.

Authors:  Roman V Shchepin; Jonathan R Birchall; Nikita V Chukanov; Kirill V Kovtunov; Igor V Koptyug; Thomas Theis; Warren S Warren; Juri G Gelovani; Boyd M Goodson; Sepideh Shokouhi; Matthew S Rosen; Yi-Fen Yen; Wellington Pham; Eduard Y Chekmenev
Journal:  Chemistry       Date:  2019-05-30       Impact factor: 5.236

3.  Spin-Lattice Relaxation of Hyperpolarized Metronidazole in Signal Amplification by Reversible Exchange in Micro-Tesla Fields.

Authors:  Roman V Shchepin; Lamya Jaigirdar; Eduard Y Chekmenev
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2018-02-27       Impact factor: 4.126

4.  Spin Relays Enable Efficient Long-Range Heteronuclear Signal Amplification By Reversible Exchange.

Authors:  Roman V Shchepin; Lamya Jaigirdar; Thomas Theis; Warren S Warren; Boyd M Goodson; Eduard Y Chekmenev
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2017-12-01       Impact factor: 4.126

5.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 6.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

7.  Quasi-Resonance Signal Amplification by Reversible Exchange.

Authors:  Thomas Theis; Nuwandi M Ariyasingha; Roman V Shchepin; Jacob R Lindale; Warren S Warren; Eduard Y Chekmenev
Journal:  J Phys Chem Lett       Date:  2018-10-10       Impact factor: 6.475

Review 8.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 9.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 10.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.